Significance of ICG fluorescence-guided navigation laparoscopic surgery for gastric and esophagogastric junction cancer

Sano Akihiko0 个研究点目标入组 150 人开始时间: 2021年6月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with resectable gastric and esophagogastric junction cancer who have pathologically diagnosed of adenocarcinoma.
•2. 20-years old and more, PS 0-2. Gender does not matter.
•3. Consent to participate in the study and the patient or his / her representative has signed the ethics committee approval consent document.

•1. Patients with active double cancer (simultaneous double cancer and metachronous double cancer with a disease-free period of up to 5 years).
•2. Patients with a history of frequent laparotomy and expected to have a high degree of intra-abdominal adhesions.
•3. Patients with a history of ICG or iodine hypersensitivity, asthma or severe drug allergies.
•4. Patients with serious comorbidities.
•5. Female patients of childbearing potential or breastfeeding.
•6. Patients receiving continuous systemic steroids (oral or intravenous).
•7. Patients with mental illness or psychiatric symptoms who are judged to be difficult to participate.
•8. In addition, patients who are judged by the principal investigator to be inappropriate for participation in this study.

发起方

Sano Akihiko